Liminatus Pharma Inc (LIMN)

Finanzdaten der Liminatus Pharma Inc-Aktie (LIMN)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	25.25%1.38	1.10	0.88	0.70	1.12
Research and Development	50.00%0.60	0.40	-	-	-
Operating Income/Loss	25.25%-1.38	-1.10	-0.88	-0.70	-1.12
Nonoperating Income/Loss	24.26%-0.03	-0.02	-7.28	-1.12	1.23
	25.23%-1.41	-1.12	-8.17	-1.82	0.11
Attributable To Parent	25.23%-1.41	-1.12	-8.17	-1.82	0.11
Basic Average Shares	34.44%48.40	36.00	-	27.01	23.30
Diluted Average Shares	34.44%48.40	36.00	-	27.01	23.30
Basic Earnings Per Share	-0.03	-0.03	-	-0.07	-
Diluted Earnings Per Share	-0.03	-0.03	-	-0.07	-